Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-25 @ 3:03 AM
NCT ID:
NCT06162533
Description:
The individual participant data of this study are available upon request with approval needed from the Austrian Agency for Health and Food Safety (AGES), Vienna, Austria, and an ethical approval or waiver by the local ethic committee for use of these data. The individual participant data are not publicly available due to restrictions pertaining to contained information that could compromise the privacy of individuals (i.e. potentially allow the identification of certain individuals based on e.g. birthdate, gender and infection or death date). Data are stored at the AGES. The same data availability rules apply to the antibody data (i.e. Anti-SARS-CoV-2 antibodies) from the Medical University of Innsbruck.
Study:
NCT06162533
Study Brief:
Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria